CGEM
Cullinan Therapeutics, Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating | ||||||
| Operating Cash Flow | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — |
| Investing | ||||||
| Capital Expenditures | 49,000 | 0 | 208,000 | 1.1M | 0 | 10,000 |
| Acquisitions | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — |
| Financing | ||||||
| Debt Repayment | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — |
| Summary | ||||||
| Free Cash Flow | -175.8M | -145.3M | -134.5M | -127.8M | -43.4M | -29.8M |
| Net Change in Cash | — | — | — | — | — | — |